🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The study investigated the 24-hour efficacy and ocular surface health with ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02802137
Treatments Being Tested
a randomized, investigator-blind, interventinal study will compare the effe...
Status
Recruiting
Location
Department of ophthalmology, rigshospitalet.glostrup
Start Date
2021-09-01
Trial ID
NCT04957329
Comparison of Efficacy and Ocular Surface Disease Assessment Between Monopr...
Status
Completed
Location
CHA University Bundang Medical Center
Start Date
2019-04-30
Trial ID
NCT04743622
The ideal dosing for preservative-free tafluprost/timolol fixed combination...
Status
Completed
Location
1st University Department of Ophthalmology
Start Date
2017-01
Trial ID
NCT03612817
Treatments Being Tested
Topical antihypertensive eye drops are a key element of modern antiglaucoma...
Status
Unknown
Location
Department of Clinical Pharmacology, Medical University of Vienna
Start Date
2015-09-17
Trial ID
NCT02585375
Treatments Being Tested
Bimatoprost 0.03% preservative free monodose eye drops solution (BUDPF) is ...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01975714
Treatments Being Tested
The purpose of this study was to assess the efficacy and tolerability of TR...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01493427
Treatments Being Tested
The purpose of this study is to investigate if changes in ocular signs and ...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01087671
Treatments Being Tested
The purpose of this study is to investigate if changes in ocular signs and ...
Status
Completed
Location
Finn-Medi Research Oy
Start Date
2008-01
Trial ID
NCT00596791
Treatments Being Tested